Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Renalase, dopamine, and norepinephrine as markers for the development of hypertension in CKD patients

Fig. 3

Kruskal Wallis ranks ANOVA analysis and post-hoc analysis of the relationship between the type of renal replacement therapy used and norepinephrine concentration. Norepinephrine concentration - differences between CKD, HD A, HD B, PD, TE A, TE B, NK groups (p = 0,002). NK - CKD control group - treated conservatively; HD A – before hemodialysis; HD B – after hemodialysis; PD – peritoneal dialysis patients; TE A - before kidney transplantation; TE B - after kidney transplantation

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us